RSV Vaccine Approved for Americans Ages 50-59
June 11, 2024
The FDA approved an RSV (respiratory syncytial virus) vaccine for people age 50 and up. The vaccine, manufactured by GSK, was already approved for use
June 11, 2024
The FDA approved an RSV (respiratory syncytial virus) vaccine for people age 50 and up. The vaccine, manufactured by GSK, was already approved for use